Too Many Unknowns In Preclinical Testing Of Percutaneous Valves – FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA is encouraging collaboration among industry, clinicians and other experts to develop preclinical tests for percutaneous heart valve replacements